Lp(a) only modestly improved prediction when added to risk estimates, but it still can be used to personalize care.

The GLUCOSE (Glucose Level Understanding and Control Optimized for Safety and Efficacy) model is based on 6,148 ICU patients ...

With the factor XI inhibitor, clinicians may have more flexibility when managing anticoagulation in this common scenario.

The combination will be available in several doses and is also approved as a first-line option for patients with hypertension ...

Karmpaliotis leaves behind a legacy of teaching his profound skills in complex PCI and his passion for patients and family.

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

The advent of ATTR-specific drugs, though pricey, is enabling better survival in these overlapping diseases, researchers say.

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

1. Be compulsive about your patients. Take no shortcuts. 2. Be curious about why we’re doing something. If there is no good ...

The aim is to “activate these guidelines in a way that they become more actionable for clinicians,” Harlan Krumholz says.

The rapid addition of small interfering RNA therapy to usual care after a recent ACS helps more patients achieve recommended ...

Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron.